LGALS1 and cardiovascular disorder: Seropian et al. (2018) reviewed the literature on galectin-1 as an emerging mediator of cardiovascular inflammation and demonstrated the important role of this protein in cardiovascular diseases including acute MI, heart failure, and ischemic stroke through its involvement in immune cell homeostasis and chronic inflammation [14].